Current location - Trademark Inquiry Complete Network - Tian Tian Fund - Proportion of reimbursement for national centralized drug procurement
Proportion of reimbursement for national centralized drug procurement
Legal analysis: the reimbursement ratio is as follows: the reimbursement ratio of patients who purchase drugs with centralized quantity (limited to medical institutions of Grade II and below) and patients who manage Class I and II "two diseases" is100%; If drugs are purchased with non-centralized quantity, the proportion of reimbursement for patients in Class I management (limited to medical institutions of Grade II and below) is 60%, while patients in Class II management are 80% in medical institutions of Grade I, 60% in medical institutions of Grade II and 40% in medical institutions of Grade III; The reimbursement rate of outpatient examination and inspection items of "two diseases" (limited to patients managed in category II) is 80% in first-class medical institutions, 60% in second-class medical institutions and 40% in third-class medical institutions. (The first category of management objects are: low-risk population of primary hypertension and patients with secondary hypertension; The second type of management objects are: hypertensive patients and diabetic patients in the middle-risk group and above of essential hypertension).

The reimbursement limit is as follows: the annual reimbursement limit for the "two diseases" of a class of management objects is 500 yuan/person/year; The annual reimbursement limit for "two diseases" of category II management objects is 1000 yuan/person/year. The reimbursement limit for patients with hypertension and diabetes is 1.500 yuan/person-year, and that for patients with chronic diseases such as hypertension or diabetes is 1.500 yuan/person-year. On this basis, the reimbursement limit for each chronic disease is increased by 200 yuan. Use the "two diseases" outpatient medical insurance reimbursement limit and the resident medical insurance outpatient chronic disease reimbursement limit.

Legal basis: People's Republic of China (PRC) Social Insurance Law.

Twenty-third employees should participate in the basic medical insurance for employees, and employers and employees should pay the basic medical insurance premiums in accordance with state regulations. Individual industrial and commercial households without employees, part-time employees who have not participated in the basic medical insurance for employees and other flexible employees can participate in the basic medical insurance for employees, and individuals pay the basic medical insurance premium in accordance with state regulations.

Twenty-eighth medical expenses that meet the basic medical insurance drug list, diagnosis and treatment items, medical service facilities standards and emergency treatment and rescue shall be paid by the basic medical insurance fund in accordance with state regulations.